Latest Content

10 of 2694 Shown
  • CML: Why Early Response Matters

    Elias Jabbour MD - 5/20/2013
    Response is the key prognostic factor for long-term outcomes in patients with CML. In this ClinicalThought post, I discuss why early response matters and offer suggestions on managing patients without optimal responses.
  • Learning Module cme-icon

    ClinicalQuiz™: Metastatic Breast Cancer Edition

    This CME-certified activity provides clinical management insights from leading experts on the care of patients with metastatic breast cancer.
    Faculty: Stefan Glück MD, PhD, Denise A. Yardley MD
    Released: 5/16/2013
  • Understanding the Needs of Younger Patients With Acute Lymphoblastic Leukemia

    In this downloadable slideset, Lauri A. Linder, PhD, APRN, CPON, provides a case-based overview of current nursing considerations in the management of adolescent and young adult patients with acute lymphoblastic leukemia.
    Date Posted: 5/2/2013
  • What Is the Best Approach in MDS When Hypomethylating Agents Fail?

    Jamile Shammo MD, FASCP, FACP - 5/1/2013
    Currently, there is no well-defined second-line or salvage therapy for these patients. Nevertheless, there are some data to guide use of available salvage regimens.
  • Understanding the Needs of Younger Patients With Hodgkin’s Lymphoma

    In this downloadable slideset, Jeanne M. Erickson, PhD, RN, AOCN, provides a case-based overview of current nursing considerations in the management of adolescent and young adult patients with Hodgkin’s lymphoma.
    Date Posted: 5/1/2013
  • Special Considerations for Adolescents and Young Adults With Hematologic Malignancies

    In this downloadable slideset, Suzanne Ameringer, PhD, RN, reviews psychosocial issues that impact the care of adolescent and young adult patients with hematological malignancies and provides nurses and their patients with potentially helpful resources available to them.
    Date Posted: 5/1/2013
  • Bladder Cancer: Are Changes in Chemotherapy Warranted?

    Derek Raghavan MD, PhD, FACP - 4/26/2013 3 comments / Last Comment: 5/5/2013
    The NCCN recently updated its guidelines for the use of chemotherapy in patients with bladder cancer. In this ClinicalThought, I explore which of these changes should definitely be applied in clinical practice and which I believe have only limited evidence to support them.
  • Advanced Non-Small-Cell Lung Cancer: Optimizing the Care of Veterans

    In this downloadable slideset, Coery Langer, MD and Martin Edelman MD summarize key concepts and treatment options in advanced non-small cell lung cancer.
    Date Posted: 4/25/2013
  • How I Manage Patients With Relapsed/Refractory T-Cell Lymphomas

    Francine Foss MD - 4/25/2013 2 comments / Last Comment: 5/6/2013
    Once patients with T-cell lymphomas relapse, they can be very challenging to treat. In this post, I explore treatment options and provide recommendations for these patients.
  • How Do We Improve Current Therapy for MCL? Here Are 4 Promising Possibilities

    James O. Armitage MD - 4/24/2013 1 comment / Last Comment: 5/15/2013
    Several recent reports of the incorporation of other drugs into the management of mantle cell lymphoma are encouraging and predict a brighter future.
10 of 2694 Shown
Show 10 More
Loading...  

Filter Content By

Topic:
Subtopic:
Content type:
Conference only:
Available for credit:
Credit type:
Languages:
Author:
Decision Support
Free
inPractice
Immediate answers to treatment questions
More than just up to date